Rigel Pharmaceuticals Inc. (New) RIGL
$42.45
-0.31%
at last close
Financials (TTM)
- Revenue
- $276.79 million
- Net Income
- $321.91 million
- Net Margin
- 116.30%
- Return on Equity
- 75.67%
- Debt-to-Equity
- —
- P/E Ratio
- 2.51
- Price / Book
- 1.87
- Price / Sales
- 2.87
Over the trailing twelve months, Rigel Pharmaceuticals Inc. (New) generated revenue of $276.79 million and net income of $321.91 million, a net margin of 116.30%.
At the last closing price of $42.45, RIGL trades at 2.51 times trailing earnings and 2.87 times sales, with a market capitalization of $795.39 million.
Key Stats
- Last Close
- $42.45
- Market Cap
- $795.39 million
- 52-Week Range
- $18.65 – $52.24
- Average Volume
- 338K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.